Where is Isabella headquartered?

Isabella is headquartered in Seoul, South Korea. The company has a team of 1-10 people.

What does Isabella do?

Isabella operates in the AI in Healthcare sector. Korean femtech digital healthcare startup developing AI-powered women's health solutions, led by an OB-GYN specialist. Combines clinical OB-GYN expertise with advanced sensor technology to deliver AI-based personalized women's health management through the home device Lunéo and companion app Coach Lunéo.

When was Isabella founded?

Isabella was founded in 2022. It is based in Seoul, South Korea.

Who is the CEO of Isabella?

조백설 (Jo Baek-seol) is the CEO of Isabella. The company was founded in 2022.

Where is Isabella located?

Isabella is headquartered in Seoul, South Korea.

What funding stage is Isabella at?

Isabella is currently at the Early Stage stage.

How many employees does Isabella have?

Isabella has approximately 1-10 employees.

Isabella

Category: AI in Healthcare

Korean femtech digital healthcare startup developing AI-powered women's health solutions, led by an OB-GYN specialist. Isabella was founded in 2022. The company is led by 조백설 (Jo Baek-seol). Based in Seoul, South Korea. Team size: 1-10. Latest round: Seed. Key investors include CNT Tech (씨엔티테크).

Founded: 2022
Headquarters: Seoul, South Korea
Team size: 1-10

Value proposition

Combines clinical OB-GYN expertise with advanced sensor technology to deliver AI-based personalized women's health management through the home device Lunéo and companion app Coach Lunéo.

Products and solutions

Lunéo (루네오) - home care device combining low-temperature plasma and LED technology, Coach Lunéo (코치 루네오) - AI companion app that analyzes biometric data and provides personalized care.

Unique value

Founder-led clinical expertise (OB-GYN) combined with low-temperature plasma + LED home device technology and AI-driven biometric analysis, backed by KAIST and KRISS technical collaboration.

Target customer

Women seeking home-based, personalized gynecological and women's health management.

Industries served

Femtech / Women's digital healthcare

Technology advantage

Differentiated sensing technology and data competitiveness built on collaboration with KAIST and KRISS (Korea Research Institute of Standards and Science); low-temperature plasma and LED fusion home device; AI-based biometric data analysis.

How they differentiate

Unlike app-only femtech competitors, Isabella combines a physical home device (Lunéo) using low-temperature plasma and LED technology with AI-driven biometric analysis, anchored by the founder's clinical OB-GYN expertise and KAIST/KRISS technical collaboration.

Main competitors

Motion Labs (모션랩스, Dr.Bella), NTL Healthcare (엔티엘헬스케어)

Key partnerships

KAIST (한국과학기술원), KRISS (한국표준과학연구원), CNT Tech (씨엔티테크, investor/accelerator)

Major milestones

Selected for the 2026 Femtech Industry Fostering Project (2026 펨테크 산업 육성 사업), raised seed funding from CNT Tech (Aug 2026), CEO participated as panelist at 2026 Femtech Plus event.

Market positioning

Early-stage femtech startup in the emerging Korean women's digital healthcare market, selected for the 2026 Femtech Industry Fostering Project.

Geographic focus

South Korea

About 조백설 (Jo Baek-seol)

OB-GYN specialist (산부인과 전문의); PhD from Hanyang University; Director of Isabella Women's Clinic (이사벨라여성의원) in Gangnam, Seoul; previously OB-GYN department head at Gangnam MizMedi Hospital and director at Floche OB-GYN Clinic

Latest news about Isabella

Isabella Raises Seed Funding from CNT Tech for AI-Driven Women's Health

More AI in Healthcare companies

Official website: http://isabella.clinic/